Natural history of systemic reactions and risk factors in children and adults with Hymenoptera venom allergy

2020 ◽  
Vol 29 (2) ◽  
pp. 26-33
Author(s):  
Darío Antolín-Amérigo ◽  
Berta Ruiz-León ◽  
A. Vega-Castro ◽  
Belén de la Hoz Caballer
2020 ◽  
Vol 29 (2) ◽  
pp. 38-45
Author(s):  
Darío Antolín-Amérigo ◽  
Berta Ruiz-León ◽  
Arantza Vega-Castro ◽  
Belén de la Hoz Caballer

2005 ◽  
Vol 35 (2) ◽  
pp. 179-185 ◽  
Author(s):  
J. Fernandez ◽  
V. Soriano ◽  
L. Mayorga ◽  
M. Mayor

2016 ◽  
Vol 116 (3) ◽  
pp. 225-229 ◽  
Author(s):  
Joanna Lange ◽  
Ewa Cichocka-Jarosz ◽  
Honorata Marczak ◽  
Agnieszka Krauze ◽  
Izabela Tarczoń ◽  
...  

2014 ◽  
Vol 4 (S1) ◽  
Author(s):  
Suleyman Tolga Yavuz ◽  
Umit Murat Sahiner ◽  
Betul Buyuktiryaki ◽  
Ebru Arik Yilmaz ◽  
Özlem Cavkaytar ◽  
...  

2017 ◽  
Vol 1 (1) ◽  
pp. 53-58 ◽  
Author(s):  
F. Ruëff ◽  
J. Kroth ◽  
B. Przybilla

2020 ◽  
Vol 21 (2) ◽  
pp. 142-152 ◽  
Author(s):  
Le Cui ◽  
Ying-Yang Xu ◽  
Xiu-Jie Wang ◽  
Kai Guan

Hymenoptera venom allergy is one of the common causes of anaphylaxis. However, when physicians make the diagnosis of Hymenoptera venom allergy, the history of being stung is not always consistent with the results of venom-specific IgE. With the development of component-resolved diagnosis, it is possible to accurately localize an allergic reaction to certain sensitized proteins. This paper reviewed the studies that have addressed the identified allergenicity and cross-reactivity of Hymenoptera venom allergens accepted by the WHO/IUIS Nomenclature Sub-committee, the componentresolved diagnosis of Hymenoptera venom allergy and its predictive values for the efficacy and safety of venom immunotherapy. Also special attention was paid to the spread of Hymenoptera venom allergy in Asian countries.


Sign in / Sign up

Export Citation Format

Share Document